These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18490617)

  • 1. Natural history of spinal-bulbar muscular atrophy.
    Chahin N; Klein C; Mandrekar J; Sorenson E
    Neurology; 2008 May; 70(21):1967-71. PubMed ID: 18490617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.
    Atsuta N; Watanabe H; Ito M; Banno H; Suzuki K; Katsuno M; Tanaka F; Tamakoshi A; Sobue G
    Brain; 2006 Jun; 129(Pt 6):1446-55. PubMed ID: 16621916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.
    Takeuchi Y; Katsuno M; Banno H; Suzuki K; Kawashima M; Atsuta N; Ito M; Watanabe H; Tanaka F; Sobue G
    Muscle Nerve; 2008 Aug; 38(2):964-71. PubMed ID: 18642379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival in amyotrophic lateral sclerosis].
    Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
    Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy.
    Hashizume A; Katsuno M; Banno H; Suzuki K; Suga N; Mano T; Atsuta N; Oe H; Watanabe H; Tanaka F; Sobue G
    Brain; 2012 Sep; 135(Pt 9):2838-48. PubMed ID: 22773541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA.
    Suzuki K; Katsuno M; Banno H; Takeuchi Y; Atsuta N; Ito M; Watanabe H; Yamashita F; Hori N; Nakamura T; Hirayama M; Tanaka F; Sobue G
    Brain; 2008 Jan; 131(Pt 1):229-39. PubMed ID: 18056738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of bulbar, upper extremity, and lower extremity motor function preservation at the time that respiratory symptoms appear in ALS].
    Kimura F; Fujimura C; Ishida S; Hosokawa T; Sato T; Nakajima H; Furutama D; Sugino M
    Rinsho Shinkeigaku; 2007 Apr; 47(4):140-6. PubMed ID: 17511283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
    Li XH; Zhuang JJ; Xie QY; Li AP; Liang XL; Feng YQ; Fang YY; Li JR; Liang YX
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1611-5. PubMed ID: 17803850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
    Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
    J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).
    Preisler N; Andersen G; Thøgersen F; Crone C; Jeppesen TD; Wibrand F; Vissing J
    Neurology; 2009 Jan; 72(4):317-23. PubMed ID: 19171827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of young-adult amyotrophic lateral sclerosis.
    Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
    Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy.
    Yamada S; Hashizume A; Hijikata Y; Inagaki T; Suzuki K; Kondo N; Kawai K; Noda S; Nakanishi H; Banno H; Hirakawa A; Koike H; Halievski K; Jordan CL; Katsuno M; Sobue G
    PLoS One; 2016; 11(12):e0168846. PubMed ID: 28005993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the size of the Golgi apparatus of spinal anterior horn cells in patients with X-linked spinal and bulbar muscular atrophy.
    Yaguchi M; Hashizume Y; Yoshida M; K Gonatas N; Okamoto K
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):17-21. PubMed ID: 12745613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
    Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.
    Hashizume A; Katsuno M; Suzuki K; Hirakawa A; Hijikata Y; Yamada S; Inagaki T; Banno H; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1026-1032. PubMed ID: 28780536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.